Geode Capital Management, LLC Orchard Therapeutics PLC Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$0.7 - $1.51 $18,255 - $39,379	26,079 New	26,079 $18,000
Q3 2021 Nov 12, 2021	SELL	$2.24 - $4.29 $73,355 - $140,488	-32,748 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.39 - $7.23 $9,113 - $15,009	2,076 Added 6.77%	32,748 $143,000
Q1 2021 May 12, 2021	BUY	$4.39 - $9.08 $134,650 - $278,501	30,672 New	30,672 $222,000
Q4 2020 Feb 12, 2021	SELL	$3.86 - $5.07 $131,274 - $172,425	-34,009 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.11 - $6.45 $13,727 - $21,543	3,340 Added 10.89%	34,009 $139,000
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $62,054 - $129,396	10,792 Added 54.29%	30,669 $184,000
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $112,305 - $312,267	19,877 New	19,877 $149,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.